G. González

发表

Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of “regression to the mean” using routine clinical features with correlating biochemical relapse rates

P. Troncoso, John W. Davis, S. Matin, 2019, Asian journal of andrology.

Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors.

Z. Estrov, H. Kantarjian, J. Cortes, 2016, Blood.

Marginal zone lymphomas

P. Iyengar, P. Mclaughlin, F. Cabanillas, 2010, Cancer.

Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2017, Blood.

An international study of interobserver variability of “string sign” of pancreatic cysts among experienced endosonographers

M. Catalano, P. Vilmann, S. Chari, 2021, Endoscopic ultrasound.

Analysis of long term responses and their impact on outcomes in patients with chronic phase CML treated with four different TKI modalities – analysis of 5 prospective clinical trials

H. Kantarjian, J. Cortes, S. Verstovsek, 2016 .

Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study.

H. Kantarjian, J. Cortes, P. Jain, 2015, The Lancet. Haematology.

Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial.

C. Wood, P. Corn, J. Karam, 2020, European urology oncology.